The effect of cyclic AMP (cAMP)-dependent phosphorylation and ADP-ribosylation on the activities of the rat liver bifunctional enzyme, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2), was investigated in order to determine the role of the N-terminus in covalent modification of the enzyme. The bifunctional enzyme was demonstrated to be a substrate in vitro for arginine-specific ADP-ribosyltransferase: 2 mol of ADP-ribose was incorporated per mol of subunit. The Km values for NADI and PFK-2/FBPase-2 were 14 gM and 0.4 ,M respectively. A synthetic peptide (Val-Leu-Gln-ArgArg-Arg-Gly-Ser-Ser-Ile-Pro-Gln) corresponding to the site phosphorylated by cAMP-dependent protein kinase was ADPribosylated on all three arginine residues. Analysis of ADPribosylation of analogue peptides containing only two arginine residues, with the third replaced by alanine, revealed that ADPribosylation occurred predominantly on the two most C-terminal arginine residues. Sequencing of the ADP-ribosylated native INTRODUCTION
INTRODUCTION
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2) catalyses both the synthesis and degradation of fructose 2,6-bisphosphate (Fru-2,6-P2), an allosteric activator of 6-phosphofructo-l-kinase and an inhibitor of fructose-1,6-bisphosphatase [1] [2] [3] . The liver enzyme consists of two identical subunits of 55 kDa, each containing two active sites, corresponding to the kinase and bisphosphatase activities. Phosphorylation of Ser-32 of liver PFK-2/FBPase-2 by cyclic AMP (cAMP)-dependent protein kinase (PKA) results in kinase inactivation and bisphosphatase activation, which explains the ability of glucagon to decrease Fru-2,6-P2 levels in liver. The bifunctional enzyme integrates a number of metabolic and hormonal signals by means of allosteric effectors and phosphorylation/dephosphorylation processes, and by regulation of its gene expression. PFK-2/FBPase-2 thus provides an important switching mechanism between glycolysis and gluconeogenesis in mammalian liver.
Recent evidence supports the hypothesis that the N-and Cterminal regions of the liver bifunctional enzyme interact individually with the kinase and bisphosphatase domains, respectively [4] . The bifunctional-enzyme homodimer has been postulated to exist in an antiparallel configuration, with the Nenzyme also demonstrated that the preferred sites were at Arg-29 and Arg-30, which are just N-terminal to Ser-32, whose phosphorylation is catalysed by cAMP-dependent protein kinase (PKA). ADP-ribosylation was independent of the phosphorylation state of the enzyme. Furthermore, ADPribosylation of the enzyme decreased its recognition by liverspecific anti-bifunctional-enzyme antibodies directed to its unique N-terminal region. ADP-ribosylation of PFK-2/FBPase-2 blocked its phosphorylation by PKA, and decreased its PFK-2 activity, but did not alter FBPase-2 activity. In contrast, cAMPdependent phosphorylation inhibited the kinase and activated the bisphosphatase. These results demonstrate that ADPribosylation of arginine residues just N-terminal to the site phosphorylated by PKA modulate PFK-2 activity by an electrostatic and/or steric mechanism which does not involve uncoupling of N-and C-terminal interactions as seen with cAMP-dependent phosphorylation.
and C-terminal regions interacting separately with the active sites of their respective domains, as well as interacting with the opposing terminus in the other domain in both the phosphorylated and dephosphorylated states [5] . In support of this hypothesis, deletion of either the N-or C-terminal regions simultaneously leads to disruption of the N-and C-terminal interactions, resulting in a 5-10-fold activation of the bisphosphatase and an inhibition ofthe kinase [6] . PKA-catalysed phosphorylation of Ser-32 causes an inhibition of the kinase and 2-4-fold activation of the bisphosphatase and phosphorylation has also been postulated to act by uncoupling the N-and Cterminal interactions [4, 5] . Another covalent modification in the N-terminal region of the enzyme, involving a group different from phosphate and with different charge, would provide an additional test for this hypothesis.
Mono(ADP-ribosyl)transferases (ADPRT) catalyse transfer of the ADP-ribose moiety from NADI to specific acceptors and are present in a large number of animal tissues. This posttranslational protein modification is a mechanism by which living organisms modify the function of many important regulatory proteins [7, 8] . There are several examples of proteins which are subject to covalent modification by both phosphorylation and ADP-ribosylation. For example, the enzyme from chicken peripheral polymorphonuclear cells [9] Abbreviations used: PFK-2, 6-phosphofructo-2-kinase (EC 2.7. catalyses the ADP-ribosylation of arginine residues in two key enzymes of carbohydrate metabolism, L-pyruvate kinase [10] and phosphorylase kinase [11] , and histone HI [12] at an arginine next to the serine that is phosphorylated by PKA [9] [10] [11] [12] . For pyruvate kinase, this leads to suppression of the subsequent phosphorylation of the enzyme. The Kemptide peptide (LeulArg-Arg-Ala-Ser-Leu-Gly7), an analogue peptide of the liver pyruvate kinase phosphorylation site and a substrate of PKA, has also been shown to be ADP-ribosylated at an arginine by this ADPRT [10] . High concentrations of this peptide suppress the phosphorylation of pyruvate kinase by PKA. However, although rat liver pyruvate kinase can be ADP-ribosylated, the enzyme activity is not affected [10] .
Since PFK-2/FBPase-2 contains an amino acid sequence (Arg28-Arg-Arg-Gly-Ser-Ser-Ile34) [1] Enzymes ADPRT was purified from chicken peripheral polymorphonuclear cells [9] or from turkey erythrocytes [13] . Rat liver PFK-2/FBPase-2 was purified as described previously [14, 15] [16] . After incubation, the samples were fractionated by SDS/PAGE (10% gel) [16] and the gel was subjected to autoradiography [17] . [19] .
Peptide synthesis Peptides were manually synthesized by the solid-phase method on a 0.7-nmol scale by a previously described protocol [20, 21] .
In addition to Bocl-Gln esterified to 1 % cross-linked chloromethylated styrene divinylbenzene (0.47 nmol/g) and t-amyloxycarbonyl-L-Arg(NG-tosyl), the following Boc-L-amino acids were used: Val, Leu-H20, Gly (4-nitrophenyl ester), Ala, Ser (O-benzyl), Thr (O-benzyl), Ile,4H2O, Pro and Boc-Gly. Dicyclohexylcarbodi-imide was used as the coupling agent other than in the active ester coupling of glutamine. Completeness of coupling of each residue was assessed by the ninhydrin test [22] . Peptides were cleaved from the resin with anhydrous HF/anisole (9:1, v/v) for 30 min at 0°C [23] . After removal of residual anisole with ethyl acetate, the peptide was extracted from the resin with 1 M acetic acid and immediately freeze-dried. The amino acid sequences of the peptides that were synthesized are shown in Table 1 .
Purfflcation and analysis of peptides Crude cleavage peptides were passed over a column (2.0 cm x 95 cm) of Sephadex G-25 (medium grade) in 10% acetic acid. The peak of peptide material was detected by the Sakaguchi reagent [24] , pooled, and freeze-dried. Final purification of samples of each peptide was achieved by HPLC on a Perkin Elmer Series 4 chromatograph linked to an LC-75 spectrophotometer set at 210 nm, an LC1-100 computing integrator, and a LKB Redirac fraction collector. Reversed-phase HPLC was performed on a semi-preparative (1.0 cm x 25 cm) column of Vydak 218TP1010, containing 300 A (30 nm)-pore-diameter 10 jum C18 bonded phase. Samples were run at room temperature at a flow rate of 5 ml/min at a column pressure of 6-7 MPa. Peptides were eluted with a mixture of solutions A and B, which contained 0.1 % trifluoroacetic acid in water and 0.1 % trifluoroacetic acid in acetonitrile respectively. The column was equilibrated in 5 % solvent B, and the elution gradient was: 0-2.5 min, 5% B; 2.5-37.5 min, 5-30% B (linear); 37.5-40.0 min, 30-70 % B (linear). The major peak was pooled and freeze-dried. Purity of peptides was assessed by TLC on cellulose sheets in the previously described solvents [20] . All peptides were pure, as determined by ninhydrin staining. Stock solutions of peptides were further analysed and,quantified by amino acid analysis-of duplicate acid hydrolysates (5.7 M HCl, 110°C, 22 h). Amino acid analysis was performed by the method of HPLC after precolumn derivative formation with phenylisothiocyanate as described by Heinrikson and Meredith [25] .
ADP-ribosylation of peptides ADP-ribosylation assays were conducted for 5 min at 30°C in a reaction mixture (final volume 0.08 ml) containing 50 or 100 mM potassium phosphate buffer (pH 6.8), 2 To determine the stiochiometry of peptide ADP-ribosylation, the above conditions were modified such that the reaction mixture contained 100 ,M peptide, 3 mM MgCl2, 0.8 mM [32P]NAD+, and either 0.2-2.0,g/ml catalytic subunit of PKA or 5-40 ng of ADPRT. All reactions were initiated by addition of enzyme, and ADP-ribose incorporation was determined by the phosphocellulose paper method [18] using a phosphoric acid procedure.
Kinetic constants were determined from initial-velocity data fitted to the Michaelis-Menten equation by the method of weighted least squares. Less than 15 % of the least abundant substrate was consumed, and reactions were linear with respect to time and amount of enzyme. Kinetic analyses were repeated at least three times.
ADP-ribosylation and phosphorylation of PFK-2/FBPase-2 ADP-ribosylation was performed as described for the standard assay, but with non-radioactive NAD+. After 30 min, the mixture was incubated in 100 mM Hepes (pH 7.1), 5 mM MgCl2, 0.5 mM [y-32P]ATP-Mg (1000 c.p.m./pmol) and 2 m-units/ml catalytic subunit of PKA (Sigma) for 30 min at 30°C, in a total volume of 25 #1. The reaction was stopped with loading buffer, and the samples were fractionated by SDS/PAGE (10% gel). The gels were subjected to fluorography or autoradiography [17] .
Phosphorylation and ADP-ribosylation of PFK-2/FBPase-2 For the assay of phosphorylation, the reaction mixture contained 20 mM Hepes (pH 7.1), 5 DTT, 50 mM Tris/HCI (pH 7.1) and 36 ng of ADPRT were added, and the mixture was incubated for 30 min at 25°C in a total volume of 25,1. The reaction was stopped by addition of electrophoresis buffer and the samples were fractionated by SDS/PAGE (10 % gel). The gels were subjected to fluorography or autoradiography.
Assay of PFK-2/FBPase-2 activities PFK-2 activity was determined by a modification of the method described by Bartrons et al. [26] . Samples were incubated at 30°C in 100 mM Hepes (pH 7.1), containing 100 mM KCI, 20mM KF, 1 mM DTT, 5mM Pi, 5mM MgCl2, 0.5mM ATP-Mg, 0.1 mM fructose 6-phosphate and 0.3 mM glucose 6-phosphate. FBPase-2 activity was assayed by measuring the rate of hydrolysis of [2-32P]Fru-2,6-P2 to [32P]Pi and fructose 6-phosphate, as described in [27, 28] . The protein concentration was-determined as described by Bradford [29] , with bovine serum albumin as standard. One unit of enzyme activity catalyses the formation of 1 umol of product per min under the specified assay conditions.
Western-blot analysis
Immunoblot analysis was performed essentially as described by Burnette [30] , with a 1: 500 dilution of polyclonal antibody raised against rat liver PFK-2/FBPase-2 [28] The thermolytic peptide containing the site ADP-ribosylated by ADPRT was isolated from PFK-2/FBPase-2 as described in the Experimental section. The peptide was subjected to automated Edman degradation in a gas-phase (ABI740A) sequenator; the product of each cycle was counted for 6erenkov radiation and analysed for amino acid phenylthiohydantoins. A sample (2 nmol) of peptide was applied to the glass-fibre filter of the ABI470 instrument. A dash indicates no positive identification of phenylthiohydantoin in amino acids. The same sequence was obtained with two different preparations of enzyme. Yields of minor amino acid at each cycle are not shown. The intensity of the labelled band was dose-and time-dependent (Figures 1 and 2 Site of ADP-ribosylatfon of liver PFK-2/FBPase-2
Amount
Since pyruvate kinase, a substrate for PKA, had been shown to be ADP-ribosylated at an arginine residue adjacent to the serine that is phosphorylated by PKA, it was decided to determine whether PFK-2/FBPase-2, also a substrate for this kinase, was also ADP-ribosylated at some arginine residue next to the phosphorylated serine. There had been a previous report of the isolation of a [32P]phosphopeptide by brief incubation of the enzyme with thermolysin after its phosphorylation by PKA [33] . The incubation with thermolysin converted the enzyme into a form with a subunit molecular mass of about 35 kDa, which contains all the 32P radioactivity located in the phosphorylationsite peptide (Val-Leu-Gln-Arg-Arg-Arg-Gly-Ser-Ser-Ile-ProGln). This peptide could be purified by ion-exchange chromatography, gel filtration and reverse-phase HPLC, and sequenced. This same approach was used to isolate the ADPribosylated thermolytic [32P]peptide for the enzyme. When PFK-2/FBPase-2 was incubated with [32P]NAD+ and ADPRT, the bifunctional enzyme was labelled to a level of 2 mol of 32P/mol of subunit. The 32P-labelled peptide was purified as described for the [32P]phosphopeptide and subjected to automated analysis using a gas-phase sequencer. Positive identification of all of the residues was obtained, with the exception of cycles 5 and 6, where no phenylthiohydantoin derivative was recovered ( 
ADP-ribosylation of phosphorylatlon-site peptides
The above results indicate that the arginines located at the phosphorylation site region, mainly Arg-29 and Arg-30, were ADP-ribosylated by ADPRT. In order to analyse the relative effect of these arginines on the extension of the ADP-ribosylation reaction, we designed several peptides containing the bifunctional-enzyme cAMP-dependent phosphorylation site sequence and with Arg replaced by Ala. The assay conditions for ADP-ribosylation were chosen as optimal for ADP-ribosylation of the parent peptide (Val-Leu-Gln-Arg-Arg-Arg-Gly-Ser-SerIle-Pro-Gln) of the synthetic peptides shown in Table 2 . Peptide 1 was readily ADP-ribosylated to about 3 mol of 32P/mol of peptide (results not shown). Each of the analogue peptides with a single arginine-to-alanine replacement was also ADPribosylated to approx. 1.5-2.0 mol of 32P/mol of peptide. The influence of various concentrations of each peptide on the initial velocity of ADP-ribosylation by ADPRT was determined, and the results are shown in Table 2 . The parent peptide had a Km of 45 1uM and a Vmax of 3 ,umol/min per mg. This peptide is a substantially better substrate for PKA, with a low-micromolar Km and a Vmax of over 13 umol/min per mg for Ser-32 phosphorylation. Peptide 2, which had two instead of three arginine residues, with the most N-terminal residue replaced by Ala, had essentially identical Vmax and Km values for ADPribosylation compared with peptide 1. Peptide 3, which had the second Arg replaced by Ala, had a Vmax only 23 % of that of the parent peptide, whereas its Km was similar to that of peptide 2. Peptide 4 was ADP-ribosylated with a Vmax only 17 % of that of the parent peptide, with a Km nearly 3-fold higher than for peptide 1. In all the cases, the Km values for the peptides were higher than the Km for the pure enzyme. All these results suggest that Arg-30 is the most preferred site, but that in the peptides all arginine residues undergo ADP-ribosylation. These results indicate that ADP-ribosylation involves preferentially the two most C-terminal arginines (equivalent positions at Arg-29 and Effect of ADP-ribosylation on PFK-2/FBPase-2 properties
In order to determine whether ADP-ribosylation of PFK-2/FBPase-2 caused any change in the properties of the bifunctional enzyme, we studied the effect of ADP-ribosylation on the phosphorylation of the enzyme. ADP-ribosylation of PFK-2/FBPase-2 blocked its phosphorylation, although phosphorylation did not suppress ADP-ribosylation ( Figure 3 ). Since phosphorylation of hepatic PFK-2/FBPase-2 modulates its activity [1] [2] [3] , we analysed the effect of ADP-ribosylation on the activity of the bifunctional enzyme. Kinase activity decreased when the enzyme was ADP-ribosylated, leading to an activity similar to that of the phosphorylated enzyme, whereas the bisphosphatase was not affected (Table 3) . We also determined whether ADP-ribosylation of PFK-2/FBPase-2 modified the recognition of the enzyife by anti-PFK-2/FBPase-2 antibodies. We used two antibodies. One antibody was against liver purified PFK-2/FBPase-2, which we refer to as 'common antibody', since it recognizes different PFK-2/FBPase-2 isoenzymes [28] , and another was against a synthetic peptide specific for the N-terminus of hepatic PFK-2/FBPase-2 [31] , designated 'liver-specific antibody'. The common antibody recognized PFK-2/FBPase-2 with the same sensitivity whether or not the enzyme was phosphorylated and ADP-ribosylated. However, when the enzyme was ADP-ribosylated, or phosphorylated and ADP-ribosylated, it was poorly recognized by the specific antibody (Table 4) .
DISCUSSION
The results presented here provide the first evidence that PFK-2/FBPase-2 can be ADP-ribosylated in vitro, with concomitant changes in its immunological and kinetic properties and in its phosphorylation by PKA. PFK-2/FBPase-2 is one of the best known protein substrates for PKA [1, 33] , and it has been suggested that the presence of three, rather than two, arginines at the phosphorylation site sequence make PFK-2/FBPase-2 an even better substrate in vitro for PKA than L-pyruvate kinase or fructose-1,6-bisphosphatase [33] . A similar mechanism may apply to the ADP-ribosylation of these enzymes in vitro by ADPRT. The results show that all three arginine residues of the parent synthetic peptide could be ADP-ribosylated, but this modification occurs preferentially at Arg-29 and Arg-30 in the native enzyme. The high affinity ofADPRT for the bifunctional enzyme (0.4 ,uM) with respect to the synthetic parent peptide (45 ,uM) ADP-ribosylation was independent of the phosphorylation state of PFK-2/FBPase-2 and suppressed its phosphorylation by PKA. The mechanism by which ADP-ribosylation blocks phosphorylation of PFK-2/FBPase-2 may be similar to that for L-type pyruvate kinase [10] , phosphorylase kinase [11] and histone HI [12] , but is unknown. The size of ADP-ribose and the proximity of the phosphorylated serine suggest a steric impediment. Pearson et al. [34] reported that the chemical modification of arginine residues in myosin light chain led to an inhibition of phosphorylation by PKA. Steric interference is also supported by the fact that the ADP-ribosylation of different protein factors with intrinsic activity for ATP or GTP hydrolysis seems to lead to suppression of the activity [35, 36] .
Neutralization of the positively charged N-terminal arginine residues by negatively charged ADP-ribose may lead to a conformational change in the enzyme molecule that modifies its immunological and kinetic properties. ADP-ribosylation and PKA-catalysed phosphorylation decreased PFK-2 activity to a similar extent, but bisphosphatase activity was not affected by ADP-ribosylation. It has been shown that N-and C-terminal subunit interactions determine the activation state of FBPase-2. Phosphorylation affects the interaction between the two domains and mimics the effects of N-or C-terminal deletions to convert the FBPase-2 domain from a low-to a high-activity-state conformation, although the phosphorylation effect is not as dramatic as deletion of either terminal region. However, uncoupling of the N-and C-terminal interactions influences, but is not necessary for, phosphorylation-induced PFK-2 inactivation [5] . The inactivation of PFK-2 by phosphorylation is probably due to the electrostatic influence of the introduced phosphoryl group, which may interfere directly with fructose 6-phosphate binding and/or induce kinase-domain conformational changes [4, 6] . Since ADP-ribosylation does not affect bisphosphatase activity, it seems reasonable to postulate that modification of the arginine residues in the phosphorylation site does not uncouple the N-and C-terminal interaction, as appears to be the case with deletion of either terminal region or PKAcatalysed phosphorylation [6] , but acts electrostatically and/or sterically to influence only the PFK-2 active site. Final resolution of the role of the N-terminal region of the enzyme will require elucidation of the three-dimensional structure of the native bifunctional enzyme and both the ADP-ribosylated and phosphorylated forms of the enzyme. The above considerations support the idea that PFK-2 activity and/or net Fru-2,6-P2 production may be regulated in vivo by a balance between phosphorylation and ADP-ribosylation. Experiments are in progress to ascertain whether the enzyme is ADP-ribosylated in vivo, but, even if this modification is not physiologically relevant, it provides another probe for studying the role of the N-terminus in controlling the enzyme's activities.
